OBJECTIVES: We evaluated the efficacy of a motivational tobacco cessation treatment combined with nicotine replacement relative to usual care initiated in inpatient psychiatry. METHODS: We randomized participants (n = 224; 79% recruitment rate) recruited from a locked acute psychiatry unit with a 100% smoking ban to intervention or usual care. Prior to hospitalization, participants averaged 19 (SD = 12) cigarettes per day; only 16% intended to quit smoking in the next 30 days. Results. Verified smoking 7-day point prevalence abstinence was significantly higher for intervention than usual care at month 3 (13.9% vs 3.2%), 6 (14.4% vs 6.5%), 12 (19.4% vs 10.9%), and 18 (20.0% vs 7.7%; odds ratio [OR] = 3.15; 95% confidence interval [CI] = 1.22, 8.14; P = .018; retention > 80%). Psychiatric measures did not predict abstinence; measures of motivation and tobacco dependence did. The usual care group had a significantly greater likelihood than the intervention group of psychiatric rehospitalization (adjusted OR = 1.92; 95% CI = 1.06, 3.49). CONCLUSIONS: The findings support initiation of motivationally tailored tobacco cessation treatment during acute psychiatric hospitalization. Psychiatric severity did not moderate treatment efficacy, and cessation treatment appeared to decrease rehospitalization risk, perhaps by providing broader therapeutic benefit.
RCT Entities:
OBJECTIVES: We evaluated the efficacy of a motivational tobacco cessation treatment combined with nicotine replacement relative to usual care initiated in inpatient psychiatry. METHODS: We randomized participants (n = 224; 79% recruitment rate) recruited from a locked acute psychiatry unit with a 100% smoking ban to intervention or usual care. Prior to hospitalization, participants averaged 19 (SD = 12) cigarettes per day; only 16% intended to quit smoking in the next 30 days. Results. Verified smoking 7-day point prevalence abstinence was significantly higher for intervention than usual care at month 3 (13.9% vs 3.2%), 6 (14.4% vs 6.5%), 12 (19.4% vs 10.9%), and 18 (20.0% vs 7.7%; odds ratio [OR] = 3.15; 95% confidence interval [CI] = 1.22, 8.14; P = .018; retention > 80%). Psychiatric measures did not predict abstinence; measures of motivation and tobacco dependence did. The usual care group had a significantly greater likelihood than the intervention group of psychiatric rehospitalization (adjusted OR = 1.92; 95% CI = 1.06, 3.49). CONCLUSIONS: The findings support initiation of motivationally tailored tobacco cessation treatment during acute psychiatric hospitalization. Psychiatric severity did not moderate treatment efficacy, and cessation treatment appeared to decrease rehospitalization risk, perhaps by providing broader therapeutic benefit.
Authors: Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George Journal: J Clin Psychiatry Date: 2012-05 Impact factor: 4.384
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: R E Glasgow; J P Mullooly; T M Vogt; V J Stevens; E Lichtenstein; J F Hollis; H A Lando; H H Severson; K A Pearson; M R Vogt Journal: Addict Behav Date: 1993 Sep-Oct Impact factor: 3.913
Authors: Lorra Garey; Kara Manning; Danielle E McCarthy; Matthew W Gallagher; Justin M Shepherd; Michael F Orr; Norman B Schmidt; Blaz Rodic; Michael J Zvolensky Journal: Addict Behav Date: 2019-02-21 Impact factor: 3.913
Authors: Kathleen B Cartmell; Mary Dooley; Martina Mueller; Georges J Nahhas; Clara E Dismuke; Graham W Warren; Vince Talbot; K Michael Cummings Journal: Med Care Date: 2018-04 Impact factor: 2.983
Authors: Bronwyn M Sinclair-White; Virginia Pressler; Tonya Lowery St John; Janice Okubo; Katie Richards; Lola H Irvin; Jay Maddock Journal: Hawaii J Med Public Health Date: 2015-04
Authors: Colleen A Redding; David Goldberg; Kathleen M Weber; Hui-Qing Yin; Andrea L Paiva; Jane Burke-Miller; Mardge H Cohen; Joseph S Rossi Journal: Transl Behav Med Date: 2020-05-20 Impact factor: 3.046
Authors: Judith J Prochaska; Sebastien C Fromont; Danielle E Ramo; Kelly C Young-Wolff; Kevin Delucchi; Richard A Brown; Sharon M Hall Journal: Nicotine Tob Res Date: 2015-04 Impact factor: 4.244
Authors: Judith J Prochaska; Sebastien C Fromont; Kevin Delucchi; Kelly C Young-Wolff; Neal L Benowitz; Stephen Hall; Thomas Bonas; Sharon M Hall Journal: Health Psychol Date: 2014-01-27 Impact factor: 4.267